Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Filings indexed 532 across all filing types
Latest filing 2022-11-25 Regulatory Filings
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Receipt of deferred consideration
Regulatory Filings Classification · 1% confidence The document is a short announcement (under 5,000 characters) issued via the London Stock Exchange's RNS (Regulatory News Service). It reports the receipt of deferred consideration from a business sale, which constitutes a corporate update on financing and cash position. Since it does not fit into specific categories like 'Capital/Financing Update' (which usually refers to new fundraising or debt issuance) or 'M&A Activity' (which refers to the deal itself rather than a post-closing cash receipt), and given its nature as a general regulatory announcement, it is best classified as a Regulatory Filing (RNS).
2022-11-25 English
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is an 'Interim Results' announcement for Omega Diagnostics Group PLC for the six months ended 30 September 2022. It contains detailed financial highlights, operational updates, a Chairman's statement, and financial performance analysis. Since it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2023
2022-11-24 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Second Price Monitoring Extension' for Omega Diagnostics Group PLC. It is a standard market regulatory announcement regarding trading mechanics rather than a financial report, management update, or corporate action. As it does not fit into specific categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2022-11-23 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange (RNS) regarding a 'Price Monitoring Extension' for Omega Diagnostics Group PLC. It is a standard regulatory market announcement regarding trading parameters rather than a financial report, management update, or corporate action. As it does not fit into specific categories like dividends, share issues, or earnings, it falls under the general regulatory filing category.
2022-11-23 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's Regulatory News Service (RNS) regarding a 'Second Price Monitoring Extension' for Omega Diagnostics Group PLC. It is a standard market announcement regarding trading mechanics rather than a financial report, governance document, or corporate action. As it does not fit into specific categories like M&A, dividends, or share issues, it falls under the general regulatory announcement category.
2022-11-23 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Price Monitoring Extension' for Omega Diagnostics Group PLC. It does not contain financial results, board changes, or other specific corporate reports. As it is a standard regulatory notification regarding trading parameters that does not fit into the other specific categories, it is classified as a Regulatory Filing (RNS).
2022-11-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.